Notice of Intent to Sole Source - Biosearch Technologies
ID: Biosearch00303Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

All Other Basic Organic Chemical Manufacturing (325199)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/f66bdbc873a447a2ac3a0e677c69dfce/view
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) intends to negotiate a sole source contract with Biosearch Technologies, Inc. for the production of PCR kits essential for the Laboratory Response Network (LRN). The procurement aims to secure proprietary reagents necessary for detecting biothreat and emerging infectious disease agents, which are critical for the preparedness and response capabilities of various federal and state agencies. These kits, which must adhere to FDA quality standards, are vital for high-security laboratories in identifying potential bioterrorism agents and ensuring public health safety. Interested parties may submit capability statements or proposals to Matthew Nelson at mnelson2@cdc.gov by December 3, 2024, at 3:30 PM EST for consideration.

    Point(s) of Contact
    Matthew Nelson
    14044984311
    mnelson2@cdc.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Notice of Intent to Sole Source - Biosearch Technologies
    Currently viewing
    Presolicitation
    Similar Opportunities
    CDC DFWED NARST Sensititre Supplies
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
    Diagnostic Test Development and Production for Emergency Response
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking proposals for the development and production of diagnostic tests aimed at enhancing emergency response capabilities for public health threats. The procurement involves multiple tasks, including the rapid development and validation of Nucleic Acid Amplification Tests for selected pathogens, regulatory submissions for Emergency Use Authorization (EUA), and the manufacturing of tests to meet outbreak demands. This initiative is critical for bolstering the national laboratory system's readiness and efficiency in addressing public health emergencies. Interested vendors must submit their proposals by December 13, 2024, with a maximum contract value of $148 million and a minimum order of $10,000. For further inquiries, vendors can contact Shayna Connery at xvj9@cdc.gov or Austin Pagliaccetti at zsm6@cdc.gov.
    Notice of the Intent to Sole Source to Roche Diagnostics for the purchase of the Cobas 5800 Classic Service Package.
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price purchase order to Roche Diagnostics for the Cobas 5800 Classic Service Package. This procurement is necessary due to the exclusive licensing agreements and proprietary data restrictions associated with the Cobas 5800 equipment, which limits service provision to Roche Diagnostics alone. The services are critical for maintaining the functionality of laboratory instruments essential for public health operations. Interested parties may express their interest and capability to respond to this requirement by emailing the contract specialist, Robert Iaropoli, at zlb5@cdc.gov, by 6:30 AM EDT on December 2, 2024. Responses received within this timeframe will be considered by the government, although this notice does not constitute a request for competitive quotations.
    66--WI-WHITNEY GENETICS LAB-ENV MASTER MIX
    Active
    Interior, Department Of The
    The U.S. Fish and Wildlife Service intends to award a sole source contract to Life Technologies Corporation for the procurement of TaqMan Environmental Master Mix, specifically for the Whitney Genetics Lab in Wisconsin. This contract is being awarded under the authority of FAR 6.302-1, which allows for a sole source procurement when only one responsible source is available, as Life Technologies Corporation holds the patent for the TaqMan Master Mix. The contract will be a firm fixed price agreement, and interested parties who believe they can meet the requirements are invited to submit a statement of capabilities to Dana Arnold at danaarnold@fws.gov. This notice serves as a special announcement and does not constitute a solicitation for competitive quotes.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    Phase I - Serological Assays for the detection and characterization of influenza viruses
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is soliciting proposals for a contract focused on the development and execution of serological assays for the detection and characterization of influenza viruses. The primary objectives include performing hemagglutination inhibition assays on human sera for vaccine effectiveness studies and creating a new serology platform that matches the capabilities of existing assays, with an expected testing volume of approximately 6,000 samples annually. This initiative is crucial for enhancing public health responses to influenza through improved detection methodologies and is set within a framework that emphasizes small business participation and adherence to federal acquisition regulations. Interested parties can contact Jennifer Gartzke at jgartzke@cdc.gov or by phone at 404-498-0020 for further details, with the contract performance period commencing on April 28, 2025, and extending through optional periods thereafter.
    66--NOI-Sole Source: V-PLEX Custom Human Biomarkers 1 kit (25-plates) that includes
    Active
    Environmental Protection Agency
    The Environmental Protection Agency (EPA) is announcing a presolicitation for a sole source procurement of the V-PLEX Custom Human Biomarkers 1 kit, which includes 25 plates featuring proinflammatory markers such as Human IL-1ß, Human IL-6, Human TNF-a, along with the V-PLEX Human IL-8 kit. This specialized laboratory equipment is crucial for conducting analytical tests related to human biomarkers, which play a significant role in environmental health assessments and research. Interested vendors should direct inquiries to Kevin Broadnax at Broadnax.Kevin@epa.gov or call 850-934-9350 for further details regarding this opportunity.
    Sequencing Kits and Accessories for Oxford Nanopore Sequencing Systems
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified sources to provide sequencing kits and accessories for Oxford Nanopore Sequencing Systems as part of a Sources Sought notice. The primary objective of this procurement is to supply the Center for Alzheimer’s Disease and Related Dementias with essential reagents for neurodegenerative disease research, particularly for long read sequencing aimed at identifying causative genes for conditions like Parkinson’s disease. This initiative is aligned with the Global Parkinson’s Genetics Program (GP2), which aims to genotype over 150,000 volunteers globally to enhance understanding of genetic risk factors. Interested companies must submit their capability statements by November 27, 2024, to Eric McKay at eric.mckay@nih.gov, with the anticipated delivery dates for the supplies spanning from September 30, 2025, to September 30, 2027.
    eDNA Autosampler Equipment
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army's W2R2 Construction Engineering Laboratory, is seeking to procure eDNA Autosampler Equipment to establish a molecular laboratory for genetic testing and analyses. The procurement includes two eDNA Autosamplers and 400 custom eDNA Self-Preserving filter packs, which must be portable, weather-resistant, and capable of automatically collecting and filtering multiple samples without extensive user training. This specialized equipment is crucial for aquatic environmental monitoring, as it allows for efficient and contamination-free sampling of environmental DNA in freshwater systems. Interested parties may submit capability statements to Olivia Farr at CERL-CT-Quotes@usace.army.mil, although this opportunity is not a request for competitive quotations and is intended for a sole source award to Smith-Root Inc. Responses are due by the specified deadline, and telephone inquiries will not be accepted.
    NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT TO RUSTICI SOFTWARE, LLC
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) intends to award a sole source contract to Rustici Software, LLC for the provision of the CourseSync software/web application, which is essential for syndicating eLearning courses across various Learning Management Systems (LMS). This contract aims to support the CDC's Public Health Infrastructure Center and Division of Workforce Development by ensuring efficient management and oversight of educational resources, thereby enhancing training initiatives for public health stakeholders. Rustici Software has been the incumbent vendor since March 2021, and the anticipated contract will cover one base year with four optional extensions, with an award date expected on November 27, 2024. Interested vendors may submit challenges to this award by November 22, 2024; for further inquiries, contact James Sprigler at dbs6@cdc.gov or 404-498-3879.